Online citations, reference lists, and bibliographies.
← Back to Search

Preoperative Staging Of Mesothelioma By 18F-fluoro-2-deoxy-D-glucose Positron Emission Tomography/computed Tomography Fused Imaging And Mediastinoscopy Compared To Pathological Findings After Extrapleural Pneumonectomy.

J. Sørensen, J. Ravn, A. Loft, J. Brenøe, A. K. Berthelsen
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVES Extrapleural pneumonectomy (EPP) in MPM may be confined with both morbidity and mortality and careful preoperative staging identifying resectable patients is important. Staging is difficult and the accuracy of preoperative CT scan, 18F-FDG PET/CT scan (PET/CT), and mediastinoscopy is unclear. The objectives were to compare these staging techniques to each other and to surgical-pathological findings. METHODS Patients had epithelial subtype MPM, age
This paper references
10.1016/J.JTCVS.2004.02.021
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.
D. Sugarbaker (2004)
Imaging of mediastinal lymph nodes
Pm Boiselle (1998)
10.1089/108497804323071913
Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.
C. Nanni (2004)
10.1056/NEJMOA022136
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
D. Lardinois (2003)
10.1016/J.JTCVS.2005.02.051
Importance of mediastinoscopy, bilateral thoracoscopy, and laparoscopy in correct staging of malignant mesothelioma before extrapleural pneumonectomy.
J. Alvarez (2005)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/J.JTCVS.2004.10.034
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
J. Erasmus (2005)
10.1016/S0022-5223(03)00207-1
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
R. Flores (2003)
10.1016/S0003-4975(96)01228-3
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
10.1016/J.LUNGCAN.2004.11.003
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.
D. Maziak (2005)
10.1148/RADIOGRAPHICS.18.5.9747607
Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.
P. Boiselle (1998)
10.1148/RADIOL.2382041977
Integrated PET/CT: current applications and future directions.
G. V. von Schulthess (2006)
10.1016/J.ATHORACSUR.2005.06.014
Extended surgical staging for potentially resectable malignant pleural mesothelioma.
D. Rice (2005)
10.1016/J.EJCTS.2006.01.015
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
I. Opitz (2006)
10.1378/CHEST.111.6.1718
Regional lymph node classification for lung cancer staging.
C. Mountain (1997)
10.1016/S0959-8049(03)00374-5
PET scan imaging in oncology.
G. Jerusalem (2003)
18 F-FDG PET for evaluating malignant pleural mesothelioma
C Nanni (2004)
Die Oncologie. Lehrbuch der Klinischen Oncologie
Jb Sørensen (2004)
10.1148/RG.241035058
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
Z. Wang (2004)
10.1067/MTC.2000.106529
Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
D. Schneider (2000)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1111/j.1440-1843.2004.00599.x
Radiology in pleural disease: State of the art
A. L. Evans (2004)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1016/J.LUNGCAN.2004.04.016
Positron emission tomography in the diagnosis of mesothelioma.
U. Haberkorn (2004)
10.1016/S0022-5223(96)70342-2
The importance of surgical staging in the treatment of malignant pleural mesothelioma.
V. Rusch (1996)
10.1016/J.LUNGCAN.2005.03.007
The role of PET in the surgical management of malignant pleural mesothelioma.
R. Flores (2005)



This paper is referenced by
THE ROLE OF RADIOLOGY IN MPM
(2018)
10.1016/j.lungcan.2013.04.019
Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
S. Boeluekbas (2013)
10.1159/000441468
An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging
Daizo Yaguchi (2015)
10.1016/j.cpet.2011.04.001
Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging.
Victor H. Gerbaudo (2011)
10.21037/shc.2018.07.01
Advances in mesothelioma imaging and implications for surgical management
K. Blyth (2018)
10.1016/j.critrevonc.2016.05.004
The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
S. Novello (2016)
10.1016/j.remn.2011.06.002
The role of FDG PET-CT in differential diagnosis of pleural pathologies.
U. Elboğa (2012)
10.1586/17476348.2016.1171147
The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence
P. Bertoglio (2016)
10.1097/JTO.0b013e3181d86ea9
Chemotherapy Induced Pathologic Complete Response in Malignant Pleural Mesothelioma: A Review and Case Report
Cecilia Bech (2010)
10.1700/1088.11927
PET scan contribution in chest tumor management: a systematic review for thoracic surgeons.
Leonardo Duranti (2012)
10.5772/55722
Malignant Pleural Mesothelioma and the Role of Non– Operative Therapies
K. Lau (2013)
10.1016/J.PNEUMO.2011.04.002
Mésothéliome pleural : où en sont la chirurgie radicale et le traitement multimodal ?
Pierre Bonnette (2011)
10.1097/CPM.0b013e318235181f
Asbestos-related Lung Disease: An Update
M. Schuhmann (2007)
10.2147/LCTT.S102113
Clinical staging of malignant pleural mesothelioma: current perspectives
M. Bonomi (2017)
Clinical implications of 18 F-fluorodeoxyglucose positron emission tomography / computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma
Y. Abe (2011)
10.1634/theoncologist.2014-0122
Current issues in malignant pleural mesothelioma evaluation and management.
J. Ai (2014)
10.2214/AJR.11.7015
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
R. Gill (2012)
10.1016/j.lungcan.2012.10.017
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough.
E. Roca (2013)
10.2214/AJR.13.10572
FDG PET/CT in the management of primary pleural tumors and pleural metastases.
Matthew J. Kruse (2013)
10.1510/icvts.2009.213611
Staging algorithm for diffuse malignant pleural mesothelioma.
M. Zieliński (2010)
10.1007/978-94-007-4783-8_3
Diagnosis and Treatment of Malignant Pleural Effusion
Sergi Call (2012)
10.1111/j.1440-1843.2010.01890.x
Translational advances in pleural malignancies
Georgios T. Stathopoulos (2011)
10.1016/j.tripleo.2010.05.009
Oral presentation of malignant mesothelioma.
L. Murray (2011)
10.1016/S1877-1203(13)70374-4
Indications et résultats du PET scanner
Bernard Maitre (2013)
10.21037/jovs.2016.07.12
Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.
Ori Wald (2016)
10.3978/j.issn.2072-1439.2013.11.28
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.
N. van Zandwijk (2013)
10.5772/31195
Monitoring of chemotherapy response in malignant pleural mesothelioma using fluorodeoxyglucose positron emission tomography.
Tatsuo Kimura (2008)
Chapter 8 Mesothelioma : An Evidence-Based Review
Julie Goudreault (2013)
10.1177/030089161209800201
PET Scan Contribution in Chest Tumor Management: A Systematic Review for Thoracic Surgeons
Leonardo Duranti (2012)
10.1016/J.REMN.2010.08.008
Utilidad de la PET-TAC 18F-FDG en la valoración prequirúrgica del mesotelioma pleural maligno tras quimioterapia neoadyuvante
Javier Orcajo Rincón (2011)
10.1007/978-3-030-16884-1_11
Role of Metabolic Imaging in Mesothelioma
Fabrizia Gelardi (2019)
10.1016/J.EJRNM.2016.12.011
Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment
Mohamed Houseni (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar